Main Content

U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards


Inspired by talented scientists and innovators around the world, CRDF Global provides grants, fellowships, and training to help them succeed in their fields and collaborate across borders.


U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards

Saturday, December 15, 2018
Tuesday, October 9, 2018

CRDF Global is accepting proposals from joint U.S., Japan, and other regional Asia-Pacific (APac) based investigators working in the field of infectious  disease and immunology research for the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards, 2019. This initiative is jointly funded by CRDF Global utilizing funds provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the Japan Agency for Medical Research and Development (AMED). USJCMSP Collaborative Awards, 2019 is the third round of a collaborative award program that was initiated in 2016 following the 50th anniversary celebration of the USJCMSP. The awards program aims to promote the inclusion of early-stage and female scientists in collaborative research.

The USJCMSP, one of the oldest bilateral programs in the history of NIH, was established in 1965 (under a U.S. Presidential-Japan Prime Ministerial level agreement) to strengthen Japanese research capacity and address issues of public health importance in the APac region. The program continues to maintain its value as a unique tool to foster U.S., Japan, and APac Region research collaboration.  The program has nine Joint Panels (AIDS; Acute Respiratory Infections; Cholera and other Bacterial Enteric Diseases; Hepatitis; Parasitic Diseases; Cancer (previously the Genes, Environment, and Diseases Panel); Nutrition and Metabolism (inactive on the U.S. side); Mycobacterial Diseases; Viral Diseases and one cross-cutting Joint Immunology Board.  

The purpose of the USJCMSP collaborative awards is to foster new or expanded infectious disease and immunology focused biomedical research collaborations between researchers in Japan, the APac region, and U.S. investigators and institutions. It is expected that proposals will focus on questions of direct relevance to the APac region that will add to global knowledge about viral diseases. The USJCMSP continues to promote collaborations, especially to include early-stage  and female scientists from around the region.
Investigators from the United States, Japan, and other APac countries are invited to jointly apply for funding for collaborative research projects focused on the areas of research listed below and other related topics. Basic and clinical immunology and endemic and emerging infectious diseases relevant to the APac region eligible for this competition are the following:

  • Acute Respiratory  Infections
  • Cholera and other Bacterial Enteric Diseases
  • Hepatitis
  • Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
  • Immunology related to Infections Diseases
  • Nutrition and Metabolism (related to Infectious Diseases and/or Immunology)
  • Parasitic Diseases
  • Resistance against Anti-Microbial/Viral Agents
  • Tuberculosis, Leprosy, and other Mycobacteria
  • Other Viral Diseases
  • Other Emerging and Reemerging Diseases

Proposal Deadline: Friday, December 14, 2018 (23:59) U.S. Eastern Standard Time (EST)

Saturday, December 15, 2018 (13:59) Japan Time


Application Package: